Analysts Set Expectations for SLNO FY2026 Earnings
Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) – Analysts at Cantor Fitzgerald issued their FY2026 earnings estimates for Soleno Therapeutics in a research report issued on Monday, June 9th. Cantor Fitzgerald analyst K. Kluska expects that the company will post earnings per share of $1.22 for the year. Cantor Fitzgerald currently has a “Overweight” rating […]
